| - Industry | - Sector | Mr. Jeff Watson CEO | TSX Exchange | - ISIN |
| CA Country | 6,216 Employees | 30 Sep 2026 Last Dividend | - Last Split | - IPO Date |
Apotex Health Corp. is a prominent pharmaceutical manufacturing company with a significant presence across Canada, the United States, Mexico, and India. Established in 1974, the company has built a reputation for developing, manufacturing, and distributing a diverse range of pharmaceutical products. Its comprehensive portfolio includes prescription medications, generic pharmaceuticals, oncology biosimilars, branded specialty drugs, and consumer health and wellness products. The company operates through three distinct business lines: conventional generic pharmaceuticals, specialty generic pharmaceuticals, and a selection of brands and biosimilars. In May 2026, Apotex Health Corp. changed its name from Artemis Parent, Inc. and continues to expand its global reach while maintaining its headquarters in Toronto, Canada. Furthermore, Apotex Health Corp. benefits from a strategic partnership with Halo Pharmaceutical, Inc., enhancing its innovation and production capabilities. Notably, Apotex Health Corp. operates as a subsidiary of SK Artemis Holdings, II, LLC.
Apotex Health Corp. offers a wide range of traditional generic medications that provide cost-effective alternatives to brand-name drugs. These pharmaceuticals are rigorously tested for quality and effectiveness, ensuring that patients receive safe and reliable options.
This category includes unique generic medications that may not be widely available. Specialty generic pharmaceuticals often target specific health conditions, ensuring that patients with complex health issues have access to essential treatments at competitive prices.
Apotex Health Corp. develops branded specialty pharmaceuticals that are designed to offer innovative treatments. Additionally, the company produces oncology biosimilars, which are biologic medical products highly similar to already approved reference products, providing effective cancer treatment options while promoting affordability.
The company also engages in the production of branded consumer health and wellness items. These products are tailored to enhance overall health and well-being, encompassing various health supplements and over-the-counter offerings that cater to consumer needs.